16 March 2011 12:28 [Source: ICIS news]
LONDON (ICIS)--Bayer MaterialScience (BMS) has completed a patent licence agreement for the use of carbon nanotubes with US-based company Hyperion Catalysis International, the German chemicals company said on Wednesday.
BMS said the agreement will strengthen its position in developing new areas of application for its carbon nanotubes, Baytubes.
Financial terms of the agreement were not disclosed.
BMS said Hyperion currently holds a portfolio of patents and patent applications covering a broad technology range, from carbon nanotubes manufacturing to a variety of current and future applications.
“We see high demand for materials with extraordinary material properties,” said Joachim Wolff, a member of the executive committee at BMS.
“This licence with BMS will further leverage Hyperion’s broad patent portfolio and capitalise on the ever-increasing demand for carbon nanotubes,” said David Wohlstadter, Hyperion’s vice president of business development.
“We feel Bayer MaterialScience is well positioned to serve and help increase this demand, while Hyperion remains committed to expanding its own sales and providing its customers with the highest quality carbon nanotube-based products,” he added.
In January 2010, BMS opened a €22m ($31m) pilot facility to manufacture carbon nanotubes at its ?xml:namespace>
($1 = €0.71)
For more on Bayer MaterialScience visit ICIS company intelligence
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections